Herbridge, 25 April 2011_Chengdu Wagott Bio-tech Co., Ltd announced that United States Patent and Trademark Office granted the company a patent related to its high pure rebaudioside A on April 12, 2011.
Wagott submited the patent application to USPTO as early as 2007. This is the first patent related to high pure Reb A to be granted by USPTO in China. Under the patent, over 99 percent pure Reb A can be produced. The patent, entitled "high-purity rebaudioside A and method of extracting same" represents that Wagott leads the world in high pure Reb A production.
Wagott recognizes and respects the intellectual property of others and is committed to protecting and enforcing its own intellectual property rights.
Copyright: www.herbridge.com
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year

